K. A. Malle Pharmaceuticals Limited

K. A. Malle Pharmaceuticals Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U70101MH1982PLC027110 Incorporated 11 May 1982 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company chemicals and materials MSME · Medium
Data last updated
Revenue · FY 2025
₹51.47 Cr
▲ 3% YoY
Net loss · FY 2025
₹3.44 Cr
Net margin -6.7%
EBITDA · FY 2025
-₹1.99 Cr
EBITDA margin -3.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1.49 Cr
Issued & subscribed
Open charges
₹47.65 Cr
Satisfied ₹10.73 Cr
Company age
44 yrs
Est. 1982
Employees · EPFO
119
Provident fund records

About K. A. Malle Pharmaceuticals Limited

Data last updated:

K. A. Malle Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Sai-Ashray Industries Limited. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 11 May 1982 and has been in existence for over 44 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U70101MH1982PLC027110. Its GSTIN is 27AAACK1518Q1ZA (Maharashtra). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.49 Cr. It was formerly known as K. A. Malle Leasing Company Limited. It is led by directors including Shanu Pramod Podar and Rahul Radheshyam Bhomavat.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2 Krishna Dham L.S. Raheja Marg Raheja Township Malad East, Mumbai, Maharashtra, India – 400097.

As per the financials filed for FY 2025, the company reported a revenue of ₹51.47 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹3.44 Cr (net margin -6.7%) and EBITDA of -₹1.99 Cr (EBITDA margin -3.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.

The company has about 119 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹47.65 Cr and satisfied charges of ₹10.73 Cr on record. Court records list 72 cases involving the company, including 33 filed by the company and 39 filed against it; 20 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.08 Cr; the latest was in October 2024. Its 6 peer companies in the Chemicals industry (API Manufacturers, Pharmaceuticals, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Unilab Chemicals and Pharmaceuticals Private Limited with revenue of ₹51.94 Cr. The company has 23 MSME Form 1 returns on record between 2019 and 2024, listing 1,691 overdue payments to 55 micro and small suppliers.

K. A. Malle Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0003163). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kamalle.com.

Company details

CIN U70101MH1982PLC027110
Registration Number 027110
Incorporation Date 11 May 1982
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Sai-Ashray Industries Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0003163
Key People
Shanu Pramod Podar Director Rahul Radheshyam Bhomavat Director Hemant Kumar Chaturvedi Director

Recognitions & Rankings of K. A. Malle Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-06-0003163

Contact details

K. A. Malle Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is kamalle.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    kamalle.com
  • Registered Address
    2 Krishna Dham L.S. Raheja Marg Raheja Township Malad East, Mumbai, Maharashtra, India – 400097
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of K. A. Malle Pharmaceuticals Limited, buy the company report.

Comprehensive company report
K. A. Malle Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of K. A. Malle Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of K. A. Malle Pharmaceuticals Limited, buy the company report.

Financials of K. A. Malle Pharmaceuticals Limited

FY 2024 filings available

K. A. Malle Pharmaceuticals Limited reported revenue of ₹51.47 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹51.47 Cr ▲ 3%
Net loss · FY 2025
₹3.44 Cr margin -6.7%
EBITDA · FY 2025
-₹1.99 Cr margin -3.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 14%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 35%
5 years · compounded
▼ 18%

Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 9%. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.99 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.44 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-3.9%
Net Profit Margin-6.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of K. A. Malle Pharmaceuticals Limited, buy the company report.

Board of directors of K. A. Malle Pharmaceuticals Limited

K. A. Malle Pharmaceuticals has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shanu Pramod Podar
Also directs: Rahul Pharma Ltd, Sai-Ashray Industries Limited
Director28 Feb 201412 Years 8 MonthsCurrent
Rahul Radheshyam Bhomavat
Also directs: Rahul Pharma Ltd, R S Residency Private Limited, Sai-Ashray Industries Limited and 3 more
Director08 Jun 20188 Years 4 MonthsCurrent
Hemant Kumar ChaturvediDirector08 Nov 20214 Years 11 MonthsCurrent
Divyakumar Jain
Also directs: Rahul Pharma Ltd, R S Residency Private Limited, Sai-Ashray Industries Limited and 3 more
Director08 Aug 20188 Years 2 MonthsCurrent
View all directors

Peer comparison

K. A. Malle Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Pharmaceuticals, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Unilab Chemicals and Pharmaceuticals Private Limited₹51.94 Cr (FY 2024)5.0%Mumbai, Maharashtra, India
Ranq Pharmaceuticals and Excipients Private Limited₹51.83 Cr (FY 2025)5.0%Thane, Maharashtra, India
Vincit Labs Private Limited₹51.7 Cr (FY 2025)-12.0%New Delhi, Delhi, India
K. A. Malle Pharmaceuticals Limitedthis company₹51.47 Cr (FY 2025)-₹3.44 Cr-6.7%3.0%119Mumbai, Maharashtra, India
Aranthaangi Chemical Products Limited₹51.44 Cr (FY 2025)10.0%Aliyanilai, Tamil Nadu, India
Mcon Rasayan India Limited₹51.43 Cr (FY 2025)21.0%Mumbai, Maharashtra, India
Ranq Remedies Private Limited₹51.43 Cr (FY 2025)5.0%Thane, Maharashtra, India

To see the full peer comparison of K. A. Malle Pharmaceuticals Limited, buy the company report.

Auditor

K. A. Malle Pharmaceuticals Limited is audited by Shankar & Kishor for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Shankar & KishorFY 2023112451W

Shareholding

The shareholding of K. A. Malle Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of K. A. Malle Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹47.65 Cr
Satisfied charges
₹10.73 Cr
Breakdown by lending institutions
The Cosmos Co-Operative Bank Ltd₹46.65 Cr
Standard Chartered Bank₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jun 200810113252The Cosmos Co-Operative Bank Ltd₹46.65 CrOpen
06 Dec 198590183896Standard Chartered Bank₹1 CrOpen
09 Apr 201310419062The Cosmos Co-Operative Bank Ltd.₹50 LakhSatisfied
21 Apr 201210353329The Cosmos Co-Op Bank Ltd₹7 LakhSatisfied
23 Jul 201110299145The Cosmos Co-Op Bank Ltd₹75 LakhSatisfied

To see the full charge records of K. A. Malle Pharmaceuticals Limited, buy the company report.

Total charge records: 25 View all charges

Deals & funding

K. A. Malle Pharmaceuticals Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.08 Cr; the latest was in October 2024.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹3.08 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Oct 2024Funding round₹2 CrInvestors: 2 individuals
Mar 2012Funding round₹52.5 LakhInvestors: Sai-Ashray Industries Limited
Oct 2009Funding round₹25.9 LakhInvestors: Sai-Ashray Industries Limited
Mar 2008Secondary share transferUndisclosedSeller: 4 individuals
Mar 2008Secondary share transferUndisclosedBuyer: Sai-Ashray Industries Limited
Seller: 4 individuals

To see the full deal history of K. A. Malle Pharmaceuticals Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

K. A. Malle Pharmaceuticals Limited has 23 MSME Form 1 returns on record between 2019 and 2024, listing 1,691 overdue payments to 55 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 55)

SupplierAmount dueDue sinceReported on
Canara Tours and Travels Private Limited
Dexo Fine Chem Private Limited
P-Four Industries
an individual supplier
an individual supplier

To see the full MSME payment records of K. A. Malle Pharmaceuticals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

K. A. Malle Pharmaceuticals Limited has a workforce of 119 employees on its EPFO records as of Apr 02, 2024, across 2 active EPFO establishments.

Employee count
119
Active EPFO establishments
2
Employee growth
-17.36%

GST

K. A. Malle Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACK1518Q1ZAMaharashtraActive01 Jul 2017
24AAACK1518Q1ZGGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of K. A. Malle Pharmaceuticals Limited, buy the company report.

Recent activity

K. A. Malle Pharmaceuticals Limited has 13 board changes on record since 2008: 4 appointments and 9 cessations. The latest: Hemant Kumar Chaturvedi ceased to be Additional Director on 30 Nov 2021.

AGM
K. A. Malle Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
K. A. Malle Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Hemant Kumar Chaturvedi ceased to be Additional Director.
Appointed
Hemant Kumar Chaturvedi was appointed as Director.
Charges
A charge registered on 21 Apr 2012 via Charge ID 10353329 with The Cosmos Co-Op Bank Ltd was fully satisfied on 05 Jul 2019.
Ceased
Divyakumar Jain ceased to be Director Appointed In Casual Vacancy.
Ceased
Rahul Radheshyam Bhomavat ceased to be Additional Director.
Appointed
Divyakumar Jain was appointed as Director.
Ceased
Pramod Banwarilal Podar ceased to be Director.
Ceased
Radheshyam Dagdulal Bhomavat ceased to be Managing Director.
Appointed
Rahul Radheshyam Bhomavat was appointed as Director.
Appointed
Shanu Pramod Podar was appointed as Director.

57 earlier events are in the company report.

Frequently asked questions

K. A. Malle Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 11 May 1982 (44+ years old) and is registered under CIN U70101MH1982PLC027110.

K. A. Malle Pharmaceuticals has 4 current directors:

The latest financial statements of K. A. Malle Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of K. A. Malle Pharmaceuticals is 27AAACK1518Q1ZA, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACK1518Q1ZG (Gujarat).

The CIN (Corporate Identification Number) of K. A. Malle Pharmaceuticals is U70101MH1982PLC027110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

K. A. Malle Pharmaceuticals has 72 court cases on record: 33 filed by the company and 39 filed against it. 20 are pending. Most are in the high courts.

K. A. Malle Pharmaceuticals was incorporated on 11 May 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.

K. A. Malle Pharmaceuticals has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.08 Cr; the latest was in October 2024.

The peers of K. A. Malle Pharmaceuticals by revenue are Unilab Chemicals and Pharmaceuticals Private Limited, Ranq Pharmaceuticals and Excipients Private Limited, Vincit Labs Private Limited, Aranthaangi Chemical Products Limited, Mcon Rasayan India Limited and 1 more, all in the Chemicals industry (API Manufacturers, Pharmaceuticals, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Hemant Kumar Chaturvedi ceased to be Additional Director on 30 Nov 2021. Hemant Kumar Chaturvedi was appointed as Director on 08 Nov 2021. Divyakumar Jain ceased to be Director Appointed In Casual Vacancy on 30 Sep 2018. K. A. Malle Pharmaceuticals has 13 board changes on record in total.

Yes, K. A. Malle Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0003163).

K. A. Malle Pharmaceuticals has 23 MSME Form 1 returns on record between 2019 and 2024, listing 1,691 overdue payments to 55 micro and small suppliers. The latest return was filed on 27 Apr 2024.